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KEY POINTS SUMMARY 
 
•! The ventilatory response to reduced oxygen (hypoxia) is biphasic, comprising an 
initial increase in ventilation followed by a secondary depression. 
•! Our findings indicate that during hypoxia in vivo, astrocytes in the pre-Bötzinger 
Complex (preBötC), a critical site of inspiratory rhythm generation, release a 
gliotransmitter that acts via the P2Y1 subtype of ATP receptor to increase 
ventilation and reduce the secondary depression. 
•! In vitro analyses reveal that ATP excitation of the preBötC involves P2Y1 receptor-
mediated release of Ca
2+
 from intracellular stores. 
•! By identifying a role for gliotransmission and the sites, P2 receptor subtypes, and 
signaling mechanisms via which ATP modulates breathing during hypoxia, these 
data advance understanding of mechanisms underlying the hypoxic ventilatory 
response and highlight the significance of purinergic signalling and gliotransmission 
in homeostatic control. 
•! Clinically, these findings are relevant to conditions in which hypoxia and 
respiratory depression are implicated including apnea of prematurity, sleep 
disordered breathing, and congestive heart failure. 
 
ABSTRACT 
 
The hypoxic ventilatory response (HVR) is biphasic, consisting of a phase I 
increase in ventilation followed by a secondary depression (to a steady-state phase II) that 
can be life-threatening in premature infants who suffer frequent apneas and enhanced 
respiratory depression. ATP released in the ventrolateral medulla during hypoxia attenuates 
the secondary depression. We explored our working hypothesis that vesicular release of 
ATP by astrocytes in the preBötzinger Complex (preBötC) inspiratory rhythm generating 
network acts via P2Y1 receptors to mediate this attenuation. Blockade of vesicular 
exocytosis in preBötC astrocytes bilaterally (using an adenovirus to specifically express 
tetanus toxin light chain (TeLC) in astrocytes) reduced the HVR in anesthetized rats, 
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indicating that exocytotic release of a gliotransmitter contributes to the hypoxia-induced 
increase in ventilation. Unilateral blockade of P2Y1 receptors via local antagonist injection 
caused an increased secondary depression, revealing that a significant component of the 
phase II increase in ventilation in vivo is mediated by ATP acting at P2Y1 receptors within 
the preBötC. In vitro responses of the preBötC inspiratory network, preBötC inspiratory 
neurons and cultured preBötC glia to purinergic agents indicate that the P2Y1 receptor-
mediated increase in fictive inspiratory frequency involves release of Ca
2+
 from 
intracellular stores and thapsigargin-sensitive increases in intracellular Ca
2+
 ([Ca
2+
]i) in 
inspiratory neurons and glia. These data suggest that ATP is released from preBötC 
astrocytes during hypoxia and acts via P2Y1 receptors on inspiratory neurons (or glia) to 
evoke Ca
2+
 release from intracellular stores and an increase in ventilation that counteracts 
the hypoxic respiratory depression. 
 
Abbreviations. AP5, D-(-)-2-amino-5-phosphonopentanoic acid; AVV, adenoviral vector; 
BME, basal medum Eagle; CNQX, 6-cyano-7-nitroquinoxaline-2,3-dione; CPA, 
cyclopiazonic acid; DLH, DL-homocysteic acid; eGFP, enhanced green fluorescent protein; 
GFAP, glial fibrillary acidic protein; GPCR, g-protein coupled receptor; HVR, hypoxic 
ventilatory response; IP3, inositol triphosphate; NTS, nucleus tractus solitarius; PKC, 
protein kinase C; PLC, phospholipase C; PNA, phrenic nerve amplitude; preBötC, 
preBötzinger Complex; SERCA, sarco/endoplasmic reticulum Ca
2+
-ATPase; SP, substance 
P; TeLC, tetanus light chain; TMPAP, transmembrane prostatic acid phosphatase; VE, 
minute ventilation; VLM, ventrolateral medulla; VT, tidal volume. 
 
INTRODUCTION  
 
Acute exposure of mammals to moderate hypoxia evokes a biphasic hypoxic 
ventilatory response (HVR), comprising an initial increase in ventilation within the first 
minute followed by a secondary depression to a lower steady-state (Moss, 2000). The 
initial, phase I increase is primarily attributed to activation of the carotid body 
chemoreceptors. The secondary depression to a lower steady-state, phase II level is largely 
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central in origin (Teppema & Dahan, 2010), is implicated in cardiovascular diseases that 
accompany obstructive sleep apnea (Horner, 2012), and may also be a factor in sudden 
explained death in epilepsy (So, 2008). Interestingly, the HVR changes developmentally. In 
adults, ventilation during phase II remains above baseline. Newborn mammals experience a 
similar phase I increase in ventilation but this is followed by a much larger respiratory 
depression during which ventilation falls below baseline (Moss, 2000). As a result, infants 
who suffer from apnea of prematurity experience frequent apneas that can lead to a life-
threatening positive feedback loop in which apnea causes hypoxia leading to respiratory 
depression and greater hypoxia. Despite its clinical significance, underlying mechanisms 
are poorly understood, reflecting, in part, variability in the severity of hypoxic stimulus 
used to study the HVR, as well as developmental and species differences in the magnitude 
of the depression and its underlying mechanisms (Funk, 2013).  
A role for ATP-mediated purinergic signaling in shaping the HVR is supported by 
data showing the release of ATP at the ventrolateral medullary surface and an enhanced 
secondary respiratory depression following application of P2 receptor antagonists to the 
ventral medullary surface in vivo (Gourine et al., 2005). In the in vitro rhythmic slice 
preparation, the activation of P2 (specifically P2Y1) receptors in the preBötzinger Complex 
(preBötC, a key site of inspiratory rhythm generation) produces a robust 2-4 fold increase 
in the frequency of fictive inspiratory burst activity (Lorier et al., 2007). Additionally, 
unanesthetized rats transfected to express transmembrane prostatic acid phosphatase 
(TMPAP, a potent ectonucleotidase) in the ventrolateral medulla (VLM) to reduce 
endogenous levels of extracellular ATP, or tetanus toxin light chain (TeLC) protein to 
block vesicular release specifically in astrocytes, exhibit a decreased HVR. Astrocytes are 
the likely source of ATP, because they have a mitochondria-based hypoxia sensing 
mechanism that can evoke vesicular release of ATP (Angelova et al., 2015). These data 
suggest that the exocytotic release of ATP from astrocytes contributes directly to the 
homeostatic hypoxic ventilatory response (Angelova et al., 2015). The sites and 
mechanisms via which ATP causes ventilation to increase during hypoxia remain to be 
determined. Our working model, depicted in Fig. 1., proposes that preBötC astrocytes sense 
reductions in O2 and respond by releasing calcium from intracellular stores (i), which 
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evokes exocytotic release of gliotransmitters, including ATP (ii). ATP then activates P2Y1 
receptors located on preBötC inspiratory neurons (iii), which leads to phospholipase C 
mediated release of calcium from intracellular stores (iv), and the modulation of 
downstream ion channels via DAG/IP3 or the activation of protein kinase C (PKC) (v).  
Within this framework, we first examined the role of gliotransmission in the phase I 
and II components of the HVR using a viral approach to disrupt vesicular release 
specifically within astrocytes of VLM in anesthetized, vagotomized adult rats. Second, 
based on data from rhythmically-active brainstem slices (Funk et al., 1997; Lorier et al., 
2004; Lorier et al., 2007; Lorier et al., 2008; Huxtable et al., 2009; Zwicker et al., 2011) 
that ATP excitation of the preBötC is mediated via P2Y1 receptors, we tested in 
anesthetized rats in vivo whether ATP released during hypoxia acts in the preBötC via 
P2Y1 receptors to increase ventilatory output and attenuate the secondary depression. 
Finally, P2Y1 receptors on neurons and astrocytes in other brain regions signal primarily 
through the Gαq/11 G-protein coupled receptor (GPCR) pathway to activate PLC and IP3-
mediated Ca
2+
 release from intracellular stores (Simon et al., 1995; von Kugelgen & 
Wetter, 2000; Sak & Illes, 2005), which modulates neuronal excitability or transmitter 
release through [Ca
2+
]i-dependent signalling. To assess the role of the Gαq/11 signaling 
pathway in mediating the excitatory actions of P2Y1 receptors on the preBötC network, we 
used rhythmic medullary slices from neonatal rats to compare the effects of P2Y1 receptor 
activation on: i) the network response before and after chelating intracellular calcium and 
inhibition of sarco/endoplasmic reticulum Ca
2+
 ATPase (SERCA), and ii) the calcium 
response evoked in inspiratory neurons and preBötC glia by P2Y1 receptor activation 
before and after SERCA inhibition. These data advance our understanding of the sites, 
receptor mechanisms and signaling cascades that underlie the contribution of astroglial 
purinergic signaling to the HVR. 
 
METHODS  
 
All the experiments were performed in accordance with the guidelines of the 
Canadian Council on Animal Care and European Commission Directive 2010/63/EU 
! &!
(European Convention for the Protection of Vertebrate Animals used for Experimental and 
Other Scientific Purposes) with project approval from the respective Institutional Animal 
Care and Use Ethics Committees. 
 
Preparations 
Adult in vivo preparations 
Adult male Sprague-Dawley rats (250-350 g) were anesthetized using isofluorane 
(3% in 100% O2) and the femoral vein was cannulated. Isofluorane anesthesia was then 
replaced with urethane (1.5-1.7 g/kg) delivered intravenously (i.v.). Additional doses of 
urethane were given as necessary. The femoral artery was cannulated to monitor arterial 
blood pressure (BP) and blood gases. The trachea was cannulated, and the vagus nerves 
resected bilaterally at the mid-cervical level to eliminate confounding effects of vagal reflex 
stimulation. From this point there were two variations of the preparation. 
For hypoxia experiments, animals were paralyzed with gallamine triethoiodide or 
pancuronium bromide (10 mg/kg i.v.; 1 mg/kg) and mechanically ventilated with a mix of 
20% or 30% O2, balance N2 (1 L/min, 60 strokes/min at ~2 ml/stroke, for a tidal volume of 
8 ml/Kg). Paralysis and pump ventilation were used to open chemoreflex loops so that 
changes in central respiratory drive would not affect blood gases. End-tidal O2 and CO2 
were monitored from a small port in the tracheal tube (PowerLab gas analyzer, ML206, AD 
Instruments, Colorado Springs, CO) to ensure that end-tidal CO2 remained constant. Blood 
gases were taken before and during the hypoxic challenges to ensure that arterial PO2, 
PCO2, and pH were within physiological ranges and consistent between control and 
experimental trials.  
Once the rat was placed in prone position in a stereotaxic device (Kopf Instruments, 
Tujunga, CA), and mechanically ventilated, the brachial plexus was exposed dorsolaterally 
behind the right shoulder blade. The phrenic nerve was isolated, cut distally, placed over 
dual platinum electrodes and embedded in kwik-sil adhesive (World Precision Instruments, 
Sarasota, FL) for long-term stability and to prevent nerve desiccation. 
Experiments that tested the acute effects of locally applying purinergic agonists into 
the preBötC were conducted in spontaneously breathing animals. Electrodes made from 
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Teflon-coated wires (AM Systems, Carolsborg, WA) were placed in the genioglossus and 
diaphragm muscles to record electromyographic activity (GGEMG and DIAEMG, 
respectively). The animal was then positioned in a stereotaxic frame in prone position. 
Body temperature was maintained at 37°C in all in vivo experiments with a servo-
controlled heating pad (Harvard Apparatus, Holliston, MA).  
 
Rhythmically-active medullary slice preparation 
Rhythmically-active medullary slices were obtained from neonatal rats (P0-P4) as 
described in detail previously (Smith et al., 1991; Ruangkittisakul et al., 2006; Zwicker et 
al., 2011). Briefly, rats were anesthetized through inhalation of isofluorane and 
decerebrated. The brainstem spinal cord was then isolated in cold artificial cerebrospinal 
fluid (aCSF) containing (in mM): 120 NaCl, 3 KCl, 1.0 CaCl2, 2.0 MgSO4, 26 NaHCO3, 
1.25 NaH2PO4, 20 D-glucose, and bubbled with 95% O2 – 5% CO2. The brainstem-spinal 
cord was pinned to a wax chuck, and serial 100-200 µm sections were cut in the rostral to 
caudal direction using a vibrating microtome (VT1000S, Leica, Nussloch, Germany). 
Sections were trans-illuminated to identify anatomical landmarks. The structure of the 
subnuclei of the inferior olive was particularly useful in defining this boundary. A 700 µm 
rhythmic transverse slice containing the preBötC was obtained. Special care was made to 
ensure that the preBötC was at the rostral surface of the slice (~0.35mm caudal to the 
caudal aspect of the facial nucleus) (Smith et al., 1991; Ruangkittisakul et al., 2006; Lorier 
et al., 2007; Ruangkittisakul et al., 2008). Rhythmic slices were pinned rostral surface up 
on Sylgard resin in a 5 ml recording chamber and perfused with aCSF at a flow rate of 15 
ml/min (dead space of perfusion system including inflow and outflow lines and chamber 
was ~20 ml). The concentration of K
+
 in the aCSF ([K
+
]e) was raised from 3 to 9 mM at 
least 30 min before the start of data collection to produce prolonged stable rhythm 
(Ruangkittisakul et al., 2006). Rhythmic slice experiments were conducted at room 
temperature (23 -24°C).  
 
Primary cultures of glia isolated from the preBötC 
Culture preparation. Cultures were prepared from 300 µm thick preBötC slices 
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from neonatal rats (P0-P4) as described in detail previously (Huxtable et al., 2010). Culture 
media were used at 37 °C. The preBötC region was collected bilaterally using 21 gauge 
tissue punches. Tissue punches were transferred to separate 15 ml conical tubes, washed 
(2×) with Dulbecco’s PBS (2 ml) (Invitrogen, Carlsbad, CA), and centrifuged (1500 × g, 1 
min). PreBötC tissue was plated directly on Thermanox plastic coverslips (Invitrogen, 
Carlsbad, CA) and placed in a T25 flask containing BME-glucose (1 ml) that was produced 
by adding to 1× basal medium Eagle solution (BME; Invitrogen, Carlsbad, CA): 3.3 mM 
glucose (final concentration of 8.8 mM), 2 mM L-Glutamine (Sigma-Aldrich, St. Louis, 
MO), penicillin/ streptomycin (10,000 U of penicillin/10,000 µg of streptomycin per ml; 
(Invitrogen, Carlsbad, CA), and 10% rat serum.  
PreBötC-containing coverslips were incubated in 1 ml of BME-glucose for the first 
24 h and 1 ml of BME-sorbitol (10% rat serum) thereafter. BME-sorbitol was equivalent to 
BME-glucose except that D-glucose was replaced with sorbitol (2.5 mM, Fisher Scientific, 
Waltham, MA) to select for glia. After 48 h, fresh media (with 2.5% rat serum) was added 
and changed every 3 days. Cultures were grown for 6 days, smeared, maintained in a 24-
well plate for 2 weeks and then imaged.  
 
Viral gene transfer in vivo 
 
Adult male rats (200-250 g) were anesthetized with a mixture of ketamine (90 
mg/kg i.p.) and xylazine (10 mg/kg, i.p). They were then placed in a stereotaxic frame, 
where a small craniotomy was performed to expose the obex. Using coordinates described 
below, adenoviral vectors were injected bilaterally into the preBötC. Glial expression of 
TeLC and enhanced green fluorescent protein (eGFP) was achieved using a bicistronic 
adenoviral vector (AVV) construct as previously described, where eGFP expression was 
linked to TeLC via a “SKIP” sequence (Angelova et al., 2015). The bicistronic construct, 
making use of the viral ribosomal skipping mechanism, allows for a high expression of 
eGFP while attenuating TeLC expression to avoid cell toxicity. Vectors contained enhanced 
shortened GFAP promoter to drive expression of TeLC and eGFP (AVV-sGFAP-eGFP-
TeLC). As a control, we used an adenovirus expressing eGFP only (AVV-sGFAP-eGFP).  
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 Viruses were diluted in HEPES buffer, and slowly injected into the preBötC under 
direct visualization (500 nl over 2 min). Following injection, the pipette remained in place 
for 5 min before withdrawal. The skin was sutured and the animal was put in post-operative 
care and closely observed throughout recovery from anesthesia. Rats were left to recover 
for 6-8 days before the in vivo experiments to ensure stable viral expression. Virus dilution 
and the post-injection incubation period were established through experiments that involved 
a series of 10-fold dilutions and incubation periods that varied from 5-9 days. Rats were 
euthanized at the end of the respective incubation period, perfused and tissue examined to 
define the dilution and incubation period that provided the strongest glial expression with 
no evidence of tissue damage. High virus concentrations produced bright yet grainy 
fluorescent expression and transfected cell bodies near the injection site were hard to locate, 
consistent with cell death/damage. Low virus concentrations yielded weaker eGFP 
fluoresence, but individual cell bodies and processes were clearly identifiable. Original 
viruses of titres 1.4 x 10
11
 (control) and 2.10 x 10
10
 (TeLC) were diluted 1:100. Viruses 
were produced and supplied by Sergey Kasparov at the University of Bristol. 
 
Immunohistochemistry 
 
At the end of the experiments, the rats were perfused transcardially with 10% saline 
(100 ml), followed by 4% paraformaldehyde (PFA, 100 ml). The brainstem was removed 
and submersion fixed for at least 24 hours in 4% PFA solution. The brainstems were 
sectioned serially into 50 µm slices in PBS solution using a vibratome (VT 1000S, Leica, 
Nussloch, Germany). The preBötC was identified based on anatomical landmarks; ~800 µm 
caudal to caudal border of the facial nucleus, at the same level as the lateral loop of the 
principal subnucleus of the inferior olive and the semi-compact nucleus ambiguus, just 
caudal to compact nucleus ambiguus (Paxinos & Watson, 2007; Ruangkittisakul et al., 
2008). The well-established preBötC marker, NK1 receptor immunolabeling, was also used 
to define the preBötC. Serial sections were examined for the region of most intense labeling 
indicative of the preBötC (Guyenet & Wang, 2001; Guyenet et al., 2002). MRS 2279 
(P2Y1 receptor antagonist) injection sites were identified via fluorescent microspheres (0.1 
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µm, yellow-green, 2% solids, Life Technologies). NK1 receptor immunolabeling was 
examined using a rabbit anti-NK1 receptor primary antibody (1:1000, cat#AB-5060, 
Millipore, Billerica, MA) with a Cy3-conjugated donkey anti-rabbit secondary (1:200, cat# 
711-165-152, Jackson ImmunoResearch, West Grove, PA). To assess viral expression, 
eGFP fluorescence was enhanced with a chicken anti-GFP primary antibody (1:1000, cat# 
GFP-1020, Aves Labs, Tigard, OR) and an AlexaFluor 488 anti-chicken secondary 
antibody (cat# A-11039, Life Technologies, Carlsbad, CA). To check glial specificity of 
viral expression we used Cy3-conjugated NeuN rabbit antibody (1:200, cat# ABN78C3, 
Millipore) to stain neuronal nuclei. Slices were mounted on slides and observed with a 
fluorescent microscope (DM5500, Leica, Nussloch, Germany) and a Hamamatsu digital 
camera. Low magnification images to assess injection site were acquired through 
MetaMorph (Molecular Devices, Sunnyvale, CA) acquisition software, and the extent of 
viral expression analyzed using ImageJ (NIH, MD) and Adobe Photoshop (San Jose, CA). 
High magnification images were taken with a confocal microscope (Leica TCS SP5, 
Nussloch, Germany) to assess cellular expression patterns. Regions of interest were 
delineated by identifying NeuN labeled neuronal cell bodies under Cy3 fluorescence and 
then switching to GFP fluorescence to check for eGFP fluorescence indicative of neuronal 
expression of virally-transfected protein. 
 
Recording of muscle, nerve, and neuronal activities 
 
In vivo recordings of EMG and phrenic nerve activities were amplified using a 
differential AC amplifier (model 1700, AM-systems, Sequim WA) and sampled at 2 kHz 
using a PowerLab 16/30 data acquisition system (AD Instruments Colorado Springs, CO). 
Phrenic nerve activity was rectified, bandpass filtered (300 Hz to 1 kHz) and the raw signal 
was integrated (time constant = 0.08s) to calculate respiratory frequency and phrenic nerve 
inspiratory burst amplitude as an index of central respiratory drive.  
In vitro recordings of inspiratory activity were made using glass suction electrodes 
(AM Systems, Carlsborg, WA) placed on the XII (hypoglossal) nerve rootlets. Inspiratory-
related field potentials were also recorded from the surface of the slice using a four-axis 
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manual manipulator to place a suction electrode (120 µm inside diameter) on the surface of 
the slice over the rostrally-exposed preBötC (Ramirez et al., 1996). The pipette was 
systematically moved in 60 µm steps until the most robust signal was detected. This 
technique was used to establish the approximate location of the preBötC to assist local drug 
injection. Signals were amplified, bandpass filtered (300 Hz to 1 kHz), rectified, integrated 
and displayed using Axoscope 9.2 (Molecular Devices, Sunnyvale CA, USA). Data were 
saved using a Digidata 1322 A/D board and Axoscope 9.2 software for offline analysis. 
Responses of cultured glia were measured using Fluo-4 Ca
2+
 imaging. Cultures 
were loaded for 45 min (35°C) with the membrane-permeant Ca
2+
-sensitive dye, fluo-4-AM 
(0.01 mM, Sigma-Aldrich, Oakville ON) in aCSF, containing the following (in mM): 117 
NaCl, 5 KCl, 1 NaH2PO4, 2 CaCl2, 1 MgSO4 , 26 NaHCO3 , and 6 glucose. Coverslips 
were then moved to the recording chamber (3 ml volume, 28°C, 6 ml/min flow rate) 
containing aCSF saturated with 20% O2, 5% CO2, 75% N2. Fluorescence intensity was 
measured using an upright microscope (Axioskop2 FS Plus, Zeiss, Oberkochen, Germany) 
fitted with a 40× water-immersion objective (NA = 0.8), xenon arc lamp (175 W, Sutter 
Instruments, Novato, CA), and a Sensi-Cam QE (PCO Tech, Romulus, MI). Imaging 
Workbench 6.0 (INDEC Bio- Systems, Santa Clara, CA) was used to control a Lambda 10-
2 shutter system (Sutter Instruments, Novato, CA). Images were acquired at 1 Hz (20 ms 
exposure). Drugs (ATP 10 µM and thapsigargin 50 nM) were applied from triple-barreled 
micropipettes using a controlled pressure source. Consecutive agonist applications were 10 
min apart. The locally-applied ATP concentration was 10-fold lower in these experiments 
compared to slice experiments because of improved drug access to glial monolayers. 
PreBötC inspiratory neuron activity was monitored in rhythmic slices using Fluo-4 
Ca
2+
 imaging or whole-cell recording.  In calibrated slices (Ruangkittisakul et al., 2006; 
Ruangkittisakul et al., 2008), the free cytosolic Ca
2+
 concentration ([Ca
2+
]i) was monitored 
by Olympus FV1000 MPE multiphoton scanning microscopy. A MaiTai-BB Ti:sapphire 
femtosecond pulsed laser set to excite at 810 nm was used for fluorescence excitation and 
an Olympus X 20 1.0 NA immersion objective was used to image the neurons. The 
membrane-permeant Ca
2+
 dye fluo-4-AM was pressure-injected (25–50 mmHg, 10 min) 
into the preBötC using a broken patch pipette filled with aCSF containing 0.5 mM Fluo-4-
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AM dissolved in dimethyl sulfoxide containing 20% pluronic acid (Sigma Aldrich, 
Oakville, ON). Neurons and glia, stained in an area of 150–300 µm diameter, were imaged 
in 30–75 µm depths for several hours at scanning rates of 2.5 Hz that are sufficient to 
resolve peaks of inspiratory-related [Ca
2+
]i rises (for details, see (Ruangkittisakul et al., 
2006; Ruangkittisakul et al., 2012). 
Whole cell recordings were obtained from preBötC inspiratory neurons in rhythmic 
slices under direct infrared differential interference contrast microscopy (IRDIC) 
visualization. A horizontal puller (P-97, Sutter Instruments, Novato, CA) was used to pull 
patch pipettes from 1.2 mm o.d. filamented borosilicate glass (Harvard Apparatus, 
Holliston, MA). Pipette resistance was 5.1 ± 0.1 MΩ. The intracellular solution used in this 
study contained (in mM): 140 potassium gluconate, 5 NaCl, 1 MgCl2, 0.1 EGTA, 10 
HEPES, and 1 glucose with pH adjust to 7.25-7.35. Intracellular signals were amplified and 
filtered (1.8 kHz low-pass Bessel filter) with a MultiClamp 700A amplifier (Molecular 
Devices, Sunnyvale, CA), acquired at 1 and 5 kHz using a Digidata 1322A A/D board 
(Molecular Devices, Sunnyvale, CA), for Axoscope 9.2 and Clampex 9.2 (Molecular 
Devices, Sunnyvale, CA), respectively, and stored to the computer’s hard disk for off-line 
analysis using Clampfit 9.2.  
ATP was excluded from the intracellular solution because its inclusion would result 
in P2 receptor desensitization as solution is pressure ejected from the pipette when 
approaching the neurons. Recordings were obtained under voltage-clamp conditions at a 
holding potential of -60 mV. Inspiratory neurons were identified based on the presence of 
rhythmic inward synaptic current inputs that were synchronized with inspiratory-related 
bursts recorded from the XII nerve rootlets. Neurons without rhythmic inputs were 
immediately discarded. Recorded neurons had an average resting potential of –48 ± 1.3 
mV, input resistance values of 189 ± 40 MΩ and series resistance averaged 19.1 ± 1.5 MΩ. 
Short voltage pulses (100 Hz, -10 mV, 3.0 ms) were used to estimate series resistance and 
whole-cell capacitance. The experiments where series resistance increased over 20% 
between control and trial conditions were excluded. Input resistance was calculated from 
the inverse of the slope of a linear regression line fitted to the I/V curves generated by 
depolarizing ramps from -90 to -40 mV. 
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Drugs and their application 
 
In vivo. DL-Homocysteic acid (DLH)(1-10 mM) and Gallamine triethoiodide  were 
obtained from Sigma-Aldrich (St. Louis, MO), while MRS 2365 (1 mM), adenosine (500 
µM) and MRS 2279 (500 µM) were obtained from Tocris Biosciences (Bristol, UK). 
Pancuronium bromide was obtained from Alamone Labs (Jerusalem, Israel). Drugs were 
made up in HEPES-buffer (containing in mM; 137 NaCl, 5.4 KCl, 0.25 Na2HPO4, 0.44 
KH2PO4, 1.3 CaCl2•2H2O, 1.0 MgSO4•7H2O, 4.2 NaHCO3, 10 HEPES) to maintain neutral 
pH. 
For preBötzinger drug injections, the head was tilted in the stereotaxic frame such 
that Bregma was 5 mm below Lambda (Gray et al., 2001). Drugs or vehicle (HEPES-
buffer) were pressure injected (Picospritzer III, Parker, Pine Brook, NJ) into the preBötC 
through a reticuled, sharp glass pipette (40 µm tip). The preBötC was located using 
stereotaxic coordinates (in mm) that, relative to obex, were 0.9 rostral, 2.0 lateral and 2.8 
ventral. Injection volume was monitored by observing the movement of the meniscus 
relative to the reticule. An excitatory response to DLH (1-10 mM) confirmed positive 
location of the preBötC (Monnier et al., 2003). MRS 2279 solution contained fluorescent 
microspheres (0.1 µm, yellow-green, 2% solids, Life Technologies) for histological 
identification of injection sites in relation to NK1 receptor immunolabeling.  
 In vitro. Adenosine triphosphate (ATP, 10 µM), MRS 2365 (10 µM, 100 µM), MRS 
2279 (500 µM), DL-2-Amino-5-phosphono-pentanoic acid (AP5, 100 µM), thapsigargin 
(100 µM, 200 µM), cyclopiazonic acid (CPA, 100 µM) and SP ([Sar
9
-Met(O2)
11
]-substance 
P (1 µM) were obtained from Tocris Biosciences. CNQX disodium salt (CNQX, 10 µM) 
and (+)-MK-801hydrogen maleate (MK-801, 100 µM) were obtained from Sigma-Aldrich 
(St. Louis, MO). Tetrodotoxin citrate (TTX, 0.5 µM) was purchased from Almone Labs 
(Jerusalem, Israel). Drugs were prepared as stock solutions in aCSF and frozen in aliquots 
except PPADS, suramin, TTX, CNQX, AP5 and MK-801 which were prepared in MilliQ 
(EMD Millipore, Billerica, MA) water. Thapsigargin and CPA required DMSO (0.2%) for 
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complete solubility. For drugs added in vitro, the final concentration of K
+
 in the drug 
solution was matched to that of the aCSF.  
Drugs were injected unilaterally into the preBötC via triple-barrelled pipettes (5-6 
µm per barrel outer diameter). Drug microinjections were controlled by a programmable 
stimulator (Master-8; A.M.P.I., Jerusalem, Israel) connected to a picospritzer (~18 psi 
Spritzer4 Pressure Micro-Injector, Bioscience Tools, San Diego, CA). Consecutive agonist 
(MRS 2365) applications were separated by a minimum of 15 min. The suction electrode 
on the surface of the slice was used to guide the initial placement of the pipette. Substance 
P (1 µM) was then locally applied to functionally identify the preBötC based on a 
characteristic immediate, 3-4 fold increase in inspiratory frequency (Lorier et al., 2007; 
Zwicker et al., 2011). The injection site was moved in a grid-like fashion until the 
characteristic response was observed. When drugs (TTX, CNQX, AP5)were added directly 
to the circulating aCSF, they were given at least 10 min to equilibrate. During fluorescent 
imaging of inspiratory neurons, thapsigargin/CPA was given 30 minutes to equilibrate with 
the slice in a re-circulated bath (5ml/min, bath volume; 20 ml). 
 
Data Analysis 
 
Airflow, and electromyographic activity from the genioglossus and diaphragm 
muscles (GGEMG and DIAEMG) were acquired from spontaneously breathing rats. Airflow 
was measured via a pneumotach (GM instruments, Killwinning, Scotland UK) connected to 
a pressure transducer (Validyne, Northridge, CA) attached to the tracheal cannula and this 
signal was used to obtain frequency, tidal volume (VT) and minute ventilation (V̇E). 
Parameters during drug application were compared with the average value during a two-
minute control period preceding drug application. Peak drug effect was defined as the 
maximum value measured in a moving average of three consecutive bursts during the first 
minute after the injection.  
Phrenic nerve activity, blood pressure and arterial blood gases were measured in 
paralyzed animals. Frequency, integrated phrenic nerve amplitude (∫PNA) and ventilatory 
output (frequency × ∫PNA) were calculated from the phrenic nerve recording in LabChart 
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(AD Instruments, Sydney, Australia), and exported to Microsoft Excel (Microsoft, 
Redmond, WA) for analysis. Respiratory parameters were calculated from 30-second time 
bins and reported relative to a two-minute control period preceding drug application. The 
HVR was characterized by comparing the peak values obtained during the initial hypoxia-
induced increases in ventilation (phase I) and during the secondary depression when 
ventilation had plateaued (phase II). The peak value during phase I represents the group 
average of individual peak values obtained from a moving average measured during the 
first 1.5 min of hypoxia. Phase II values represent the average measured over the last 2 min 
of hypoxic exposure (shaded areas in Figs. 1, 6 and 7). All signals from the in vivo 
experiments were acquired and integrated in LabChart (AD Instruments, Sydney, 
Australia). 
 XII nerve activity from rhythmic slices was analyzed offline using Clampfit 9.2 
software (Molecular devices, Sunnyvale, CA) and Microsoft Excel (Microsoft, Redmond 
WA). To assess the effects of a specific agent on the frequency response evoked by local 
injection of P2 receptor agonists into the preBötC, we compared the relative increase in 
peak frequency evoked by the agonist in control and in the presence of drug. Baseline 
frequency was the average frequency measured over the 2 min immediately prior to drug 
application. Peak frequency was the peak value in the first min of drug application obtained 
from a moving average calculated based on three consecutive XII bursts (Huxtable et al., 
2010; Zwicker et al., 2011). 
Differences between means were compared using either GraphPad Prism (Version 
4, GraphPad Software Inc, La Jolla, CA) or SPSS (Version 20, IBM, North Castle, NY). 
For comparison of two groups, paired or unpaired t-tests were used as appropriate. For 
comparison of more than two groups, ANOVA was used in conjunction with either a Tukey 
or Bonferroni post hoc multiple comparison test. P values < 0.05 were considered 
significant. Group data are presented as boxplots created by the web-application 
‘BoxPlotR’ (Spitzer et al., 2014). Each boxplot details the spread of data points, which are 
superimposed on each box. Whiskers are defined by the lowest point, 1
st
 quartile, median, 
3
rd
 quartile and highest point, denoted by the lower whisker, bottom, middle, top of box, 
and top whisker respectively. The mean for each group is denoted by “+”. 
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RESULTS 
 
Astroglial vesicular mechanisms contribute to the hypoxic ventilatory response in vivo 
 
The expression of tetanus toxin light chain protein (TeLC) in astrocytes of the 
ventrolateral medulla (including, but not limited to the preBötC) to block vesicular release 
mechanisms attenuates the hypoxia-induced increase in ventilation in conscious adult rats 
(Angelova et al., 2015). This reduced ventilatory response indicates a significant 
contribution of medullary astroglia to the hypoxia-induced increase in ventilation, by the 
release of gliotransmitters, namely ATP (Fig. 1 (ii)). The HVR, however, is biphasic, 
comprising of an initial increase (phase I) and a secondary depression to a lower steady-
state (phase II). Thus, our first objective was to re-examine the contribution of glial 
vesicular release mechanisms to the HVR, specifically focusing on phases I and II of the 
HVR. 
Five to seven days after viral injection, the rats were anesthetized, paralyzed, 
vagotomized and mechanically ventilated. Phrenic nerve activity, BP and blood gases were 
monitored and the HVR compared between three groups of rats: naïve, control animals 
expressing eGFP in medullary astrocytes, and rats expressing TeLC and eGFP in medullary 
astrocytes. Baseline parameters were measured in normoxia (30% O2/70% N2) for two min. 
Animals were then exposed to 5.5 min of hypoxia (10% O2, 90% N2) and returned to 
normoxia for two min. Sample traces from individual control and TeLC animals as well as 
time courses calculated for group data are shown in Fig. 2A, B and reported relative to 
baseline. Comparisons of phase I and II parameters for the three groups are reported in Fig. 
2C. During phase I, the frequency and amplitude of the phrenic nerve discharge in naïve 
animals (n = 10) increased to a maximum of 1.41 ± 0.10 and 1.30 ± 0.04 of baseline 
respectively, giving a ventilatory output that was 1.79 ± 0.13 fold greater than the baseline. 
Rats transduced to express eGFP (n = 6) showed similar phase I increases in frequency, 
amplitude and the overall ventilatory output of 1.35 ± 0.04, 1.44 ± 0.09 and 1.83 ± 0.09, 
respectively. The phase I response of rats expressing TeLC in medullary astrocytes was 
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significantly reduced. Frequency and PNA amplitude were 1.16 ± 0.03 (n = 6) and 1.25 ± 
0.04 (n = 6) of control. Ventilatory output increased to 1.35 ± 0.06 (n = 6) of baseline, 
which was significantly smaller than in the naïve rats and animals transduced to express 
eGFP (p = 0.038, p = 0.041 One-way ANOVA, Tukey post-hoc test).  
During phase II of the HVR, the increases in frequency and PNA amplitude were 
not significantly different between the three groups. Frequency was 1.16 ± 0.07, 1.15 ± 
0.04 and 0.97 ± 0.04, and PNA amplitude was 1.28 ± 0.04, 1.29 ± 0.08 and 1.17 ± 0.04 for 
naïve, viral control and TeLC expressing rats, respectively. Ventilatory output, however, 
was significantly lower in the TeLC expressing rats (1.12 ± 0.04) compared to naïve (1.49 
± 0.09) and eGFP expressing rats (1.48 ± 0.09)  (p = 0.024, 0.048, One-way ANOVA, 
Tukey post-hoc test). These data indicate that the vesicular release of gliotransmitters by 
preBötC astrocytes contributes to the enhanced ventilatory activity in both phases of the 
HVR. 
Postmortem analysis of serial 50 µm transverse brainstem sections from animals 
expressing eGFP and TeLC in medullary astrocytes revealed the extent of viral expression 
across the ventral respiratory column (VRC) (Fig. 3A). Viral expression was similar in both 
groups. It was strongest at the level of the preBötC where the injection pipette tracts were 
visible. The injection sites were located ~750-850 µm caudal to the caudal border of the 
facial nucleus at the same level as anatomical markers of the preBötC (lateral loop of the 
principal subnucleus of the inferior olive and the semi-compact division of nucleus 
ambiguus, just caudal to its compact formation (Paxinos & Watson, 2007; Ruangkittisakul 
et al., 2008). The strongest viral expression also overlapped with the site along the VRC 
with the highest density of NK1 receptor immunolabeling (Fig. 3B), an established marker 
of the preBötC (Gray et al., 1999; Guyenet & Wang, 2001; Guyenet et al., 2002). Viral 
expression dropped off substantially 500 µm rostral and caudal to the injection site centered 
in the preBötC (Fig. 3A).  
The morphology of all eGFP and TeLC-expressing cells was consistent with 
astrocytic targeting, as described in detail previously  (Gourine et al., 2010; Angelova et 
al., 2015). The selectivity of our viral vectors in transfecting medullary astrocytes has been 
demonstrated (Liu et al., 2008; Gourine et al., 2010; Tang et al., 2014). To further ensure 
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the specificity, we examined 253 transduced cells from 3 sections from 3 different animals 
for co-localization of eGFP expression with the immunoreactivity for a neuron specific 
marker, NeuN. A representative example of eGFP and NeuN immunostaining and their 
overlay is shown in Fig. 3C. Ten NeuN labeled cells are circled to facilitate comparison. 
None of the NeuN labeled cells were transduced to express eGFP. 
 
P2Y1 receptor activation in the preBötC increases respiratory frequency in adult rats 
in vivo 
 
The experiments involving blockade of astroglial vesicular mechanisms using TeLC 
described above do not identify the gliotransmitter(s) that excites the preBötC network, but 
substantial evidence points to the involvement of ATP (Gourine et al., 2005; Angelova et 
al., 2015). The next objective was to assess whether P2Y1 receptors mediate the actions of 
ATP in the preBötC in vivo (Fig. 1, (iii)). Local injection of ATP into the preBötC of 
neonatal rhythmically-active medullary slices causes a site-specific, P2Y1 receptor-
mediated increase in inspiratory-related frequency (Lorier et al., 2004; Lorier et al., 2007). 
We therefore tested whether local, unilateral injection of the P2Y1 receptor agonist, MRS 
2365 (1 mM, n = 8) into the preBötC of anesthetized, vagotomized spontaneously-
breathing adult rats increases respiratory frequency.  
The preBötC was functionally identified based on the stereotypical response to a 
microinjection of DLH (10 mM) that comprises a rapid-onset increase in inspiratory 
frequency and decrease in burst amplitude (Monnier et al., 2003), as shown in Fig. 4A. If a 
response was not evoked at the initial site the pipette was moved in a grid-like manner until 
the expected response was observed. The excitatory effect of DLH was limited to a 
relatively small area. Injections 200 µm rostral to the preBötC (presumably in the BötC) 
reduced inspiratory frequency (Fig. 4B) while injections 300 µm caudal had no effect on 
breathing (Fig. 4C). 
A typical response of MRS2365 injection into the preBötC is illustrated in Fig. 5A. 
This recording, its corresponding time course (Fig. 5B) and group data (Fig. 5C) show that 
MRS 2365 microinjections into the preBötC in vivo significantly increased respiratory 
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frequency to 1.44 ± 0.09 of control (p = 0.0013). VT decreased to 0.60 ± 0.09 of control (p 
= 0.0054). The amplitude of ∫DIAEMG and ∫GGEMG (not shown) inspiratory bursts 
decreased similarly to 0.60 ± 0.10 (p = 0.0049) and 0.60 ± 0.05 (p = 0.0002) of control, 
respectively (Fig. 5C). The increase in frequency and decrease in VT offset each other such 
that minute ventilation (VE) was not significantly affected by P2Y1 receptor activation, as 
expected in an actively breathing animal with intact chemoreceptor feedback mechanisms. 
Control (saline) injections into the same brainstem sites had no significant effect on the 
respiratory frequency, VT or VE.  
Histological analysis of brainstem sections confirmed the functional DLH mapping. 
The fluorescent microspheres that marked the MRS 2365 injection sites were localized in a 
region corresponding to the preBötC based on anatomical criteria and the relationship to 
NK1 receptor immunolabeling as described above (Fig. 5D). Injection sites are mapped 
onto a schematic (Fig. 5D, left side). A representative injection site (red fluorescence) is 
also shown (Fig. 5D, right side). 
 
Adenosine injection into the preBötC has no effect on ventilation in adult rats in vivo 
 
Extracellular ATP is degraded rapidly by ectonucleotidases ultimately into 
adenosine, which can inhibit respiratory activity (Herlenius et al., 1997; Huxtable et al., 
2009; Zwicker et al., 2011). However, sites, mechanisms and the effects of adenosine 
appear to be species- and age-dependent (Huxtable et al., 2009; Zwicker et al., 2011). In 
the rat in vitro, adenosine application in the preBötC inhibits inspiratory frequency from 
embryonic stages until P2-3 (Herlenius et al., 1997; Huxtable et al., 2009). To determine 
whether the generation of adenosine from hydrolyzed ATP could could have a confounding 
influence on responses evoked by ATP released by preBötC astrocytes in adult rats, we 
microinjected adenosine (500 nl, 500 µM) unilaterally into the preBötC of adult, 
anesthetized, vagotomized rats. The representative traces and group data (Fig. 6A and C) 
show that injections of adenosine had no significant effect on ventilation. Frequency, VT 
and VE were 1.09 ± 0.03, 1.02 ± 0.01 and 1.09 ± 0.02 of control, respectively (n = 7, paired 
t-test p > 0.05). Responses elicited by DLH delivery into the same brainstem sites 
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confirmed that the injections were placed within the preBötC (Fig. 6C). DLH caused a 
significant and rapid 1.36 ± 0.05 fold (p = 0.004) increase in frequency and parallel 
decrease in VT to 0.67 ± 0.04 of control (p = 0.002) (Fig. 6C). Fluorescently-marked 
adenosine injection sites mapped to the preBötC based on anatomical landmarks (Fig. 6D). 
Fig. 6E shows a high magnification fluorescent image in which fluorescent microspheres 
that mark the injection site are in a region of strong NK1 receptor immunoreactivity.  
 
P2Y1 receptor blockade in the preBötC of adult rats increases the secondary hypoxic 
respiratory depression 
 
Given that ATP released in the ventral respiratory column during hypoxia 
counteracts the secondary respiratory depression (Gourine et al., 2005), and that ATP 
evokes P2Y1 receptor mediated increases in respiratory activity by acting within the 
preBötC in vitro (Lorier et al., 2007) and in vivo (Fig. 5), we tested the hypothesis that the 
secondary hypoxic depression is counteracted by ATP-induced activation of P2Y1 receptors 
in the preBötC (Fig. 1 (iii)). We compared the HVRs of adult, urethane-anesthetized, 
paralyzed, mechanically ventilated and vagotomized rats following unilateral 
microinjections of vehicle (0.2 µl HEPES buffer) or the P2Y1 receptor antagonist, MRS 
2279 (0.2 µl, 500 µM) into the preBötC, two min prior to the onset of hypoxia. Integrated 
phrenic nerve activity (∫PNA) was monitored as an index of central respiratory drive for 
two min in normoxia (30% O2 - 70% N2), five min in hypoxia (10% O2 - 90% N2) and then 
during the return to normoxia. Vehicle and MRS 2279 hypoxia trials were separated by one 
hour to ensure that the animals had fully recovered from the first hypoxic challenge. 
Representative recordings of ∫PNA in Fig. 7 show the hypoxic responses of one animal 
after vehicle and MRS 2279 microinjections into the preBötC. Blockade of P2Y1 receptors 
with MRS 2279 had no effect on the initial phase I of the HVR. In the control (after 
microinjections of the vehicle) hypoxia trials, frequency, burst amplitude and ventilatory 
output increased in phase I to levels that were 1.42 ± 0.08, 1.52 ± 0.11, and 1.83 ± 0.23 fold 
greater than baseline, respectively. In MRS 2279, hypoxia evoked phase I increases in 
frequency, burst amplitude and ventilatory output that were 1.17±0.06, 1.23 ± 0.06 and 
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1.36±0.11 of baseline. Only the change in burst amplitude was significantly reduced 
compared to control during phase I (p=0.038, paired t-test, n=6).  
In contrast, MRS 2279 significantly reduced the respiratory activity during phase II 
of the HVR. In the vehicle trials, during phase II, frequency fell to 0.95 ± 0.07 of baseline 
and burst amplitude remained elevated at 1.34 ± 0.09 of baseline such that ventilatory 
output remained above the baseline level recorded during normoxia (1.28 ± 0.15). After 
MRS 2279 application, frequency and VE fell to the levels significantly below that seen in 
the vehicle controls and below baseline. Frequency fell to 0.62 ± 0.10 (p = 0.045, paired t-
test, n = 6) of control while ventilatory output was 0.73 ± 0.14 (p = 0.0270, paired t-test, n 
= 6) of baseline. Group data are summarized in Fig. 7B Injection sites marked with 
fluorescent microspheres localized to the preBötC anatomically and based on the pattern of 
NK1 receptor immunolabeling (Fig. 7C).  
To ensure that the greater hypoxic depression following MRS 2279 microinjections 
into the preBötC was not due to time-dependent changes in the HVR with repeated hypoxic 
exposures, we performed a control series of experiments in which the hypoxia protocol was 
repeated at a one hour interval but the first and second hypoxic challenges were preceded 
by a vehicle injection. The frequency, ∫PNA amplitude and ventilatory output responses to 
the two consecutive hypoxic responses were not significantly different (Fig. 8, n=5). 
Comparison of the second hypoxia response in this time control series with the hypoxia 
response in MRS 2279 from the previous series (i.e., unpaired data) also showed that 
during phase II MRS 2279 caused a significant reduction in both frequency and ventilatory 
output (p = 0.01 and 0.03 respectively, independent samples t-test).   
 
Increases in [Ca
2+
]i contribute to the excitatory actions of P2Y1 receptor activation on 
the inspiratory rhythm generated by the preBötC  
 
Activation of P2Y1 receptors in the preBotC increases respiratory activity in vivo 
and in vitro (Funk et al., 1997; Lorier et al., 2004; Lorier et al., 2007; Lorier et al., 2008; 
Huxtable et al., 2009; Zwicker et al., 2011). We used rhythmic slice preparations to 
examine the signaling pathways via which P2Y1 receptor activation excites the preBötC 
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network. Analyses of recombinant P2Y1 receptors and native P2Y1 receptors in other brain 
regions indicate that responses depend on increases in [Ca
2+
]i (Rajani et al., 2015). As 
depicted in Fig. 1, [Ca
2+
]i dependent pathways can increase excitability by modulating the 
activity of multiple ion channels (Fig. 1 iv, v). We therefore tested the hypothesis that 
increases in [Ca
2+
]i are necessary for P2Y1 receptor activation to increase inspiratory 
frequency. We compared the responses of the preBötC network to local MRS 2365 
administered after local application of vehicle or the Ca
2+
 chelator, EGTA-AM (1 mM). We 
used MRS 2365 rather than ATP because the frequency effect is mediated by P2Y1 
receptors and because MRS 2365 avoids the confounding inhibitory actions on neonatal 
networks of adenosine that is generated from the degradation of ATP by endogenous 
ectonucleotidases. Vehicle and EGTA-AM (1 mM) were locally applied to the preBötC for 
5 min (5 s on, 5 s off), prior to local application of MRS 2365 (10 s, 100 µM). As shown 
for a single slice preparation and group data in Fig. 9A, EGTA-AM significantly reduced 
the MRS 2365 response from a 2.1 ± 0.14 fold increase in control to a 1.5 ± 0.08 fold 
increase in EGTA-AM (n = 6, p = 0.0047, paired t-test).  
To assess whether the increase in intracellular Ca
2+ 
that contributes to the P2Y1 
receptor evoked frequency increase is derived from intracellular sources, we next compared 
control MRS 2365 responses evoked after vehicle application with those evoked after local 
application of thapsigargin (200 µM) to the preBötC, a sarco/endoplasmic reticulum Ca
2+
 
ATPase (SERCA) inhibitor that depletes intracellular calcium stores. The target of 
thapsigargin is intracellular. Thus, additional time was allowed for thapsigargin to diffuse 
into the tissue and cross cell membranes. MRS 2365 applications were preceded by 30 
minutes of pre-application (5s on, 5s off) of vehicle or thapsigargin. The response of a 
single preparation and group data are shown in Fig. 9C and 9D, respectively. Following 30 
minutes of application, thapsigargin reduced the MRS 2365 evoked frequency increase 
from a 2.59 ± 0.15 fold increase to 1.90 ± 0.21 (n = 6, p=0.007, paired t-test). A series of 
control experiments comparing the response of MRS 2365 before and after 30 min local 
application of DMSO (0.2%) established that the thapsigargin-mediated inhibition was not 
due to the actions of the vehicle. Vehicle application for 30 minutes did not affect the MRS 
2365 response (n=5, p>0.05, paired t-test). 
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P2Y1 receptor activation increases Ca
2+
i in preBötC inspiratory neurons and glia  
 
The EGTA and thapsigargin induced reductions in the P2Y1 receptor-evoked 
frequency increase indicates that increases in [Ca
2+
]i  are an important part of ATP 
mediated excitatory signaling in the preBötC. These data, however, do not establish 
whether the ATP-evoked frequency increase depends on an increase in neuronal [Ca
2+
]i, 
(Fig. 1 iv), glial [Ca
2+
]i, (Fig. 1 ii) or both. To gain insight into the cells that mediate the 
network excitation we tested whether inspiratory neurons and glia in the preBötC respond 
to ATP with an increase in [Ca
2+
]i. 
To test neuronal sensitivity we loaded the preBötC of rhythmic slices with the Ca
2+
-
sensitive dye, Fluo-4. Fluo-4 fluorescence and XII inspiratory nerve activity were recorded 
during local application of MRS 2365 (100 µM) to the preBötC. Inspiratory neurons were 
identified by rhythmic increases in the Fluo-4 signal in phase with the rhythm recorded 
from the XII nerve (Fig. 10). Five such neurons are marked with arrows in Fig. 10A and 
their baseline, inspiratory-related oscillations in [Ca
2+
]i are apparent in the recordings of 
fluorescence intensity (Fig. 10B). Local application of MRS 2365 (100 µM) near the 
surface of the slice evoked significant increases in preBötC frequency and the Fluo-4 signal 
in all 5 inspiratory neurons imaged in this slice (Fig. 10B). Group data taken from 18 
inspiratory neurons in 5 slices showed a similar 1.53 ± 0.06 fold increase in the fluo-4 
[Ca
2+
]i signal (Fig. 10C) (n=18 from 5 slices, p <0.0001, paired t-test).  
To test whether the MRS 2365-evoked increase in [Ca
2+
]i derives from intracellular 
sources, we compared the MRS 2365 response in control (1 min, 10 µM) with that evoked 
after the SERCA blocker thapsigargin (100 µM) or CPA (100 µM) was bath applied for 30 
minutes. To account for any changes to the MRS 2365-evoked fluorescence due to 
photobleaching, two consecutive control MRS 2365 applications were applied 30 minutes 
apart. The second control MRS 2365 response was then followed by the application of 
thapsigargin or CPA for 30 min and another MRS 2365 application. Two inspiratory 
neurons are marked in Fig 10D, along with their Fluo-4 fluorescence signals in Fig 10E. 
We compared the decrease in fluorescence that occurred between MRS 2365 control trial 1 
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and control trial 2 with the decrease observed between control trial 2 and the trial with 
SERCA blockers. Thapsigargin (n=8 neurons, 4 slices) and CPA (n=4 neurons, 1 slice) had 
similar effects on the MRS 2365 evoked increase in Ca
2+ 
fluorescence, so these data were 
pooled (n=12 neurons, 5 slices). There was only a small decrease in Ca
2+
 fluorescence 
between the two control trials; trial 2 response was 95.0 ± 2.7 % of the first. In marked 
contrast, the reduction in the Ca
2+
 fluorescence response between the MRS 
2365/thapsigargin trial and control trial 2 was significantly greater than the reduction in the 
MRS 2365 fluorescence response that occurred between control trials 1 and 2. In 
thapsigargin/CPA, the MRS 2365 evoked fluorescence increase was only 43.9 ± 7.3% of 
control trial 2 (n=12, p<0.0001, paired t-test) (Fig. 10F).  
While the preBötC is the critical site for inspiratory rhythm generation, it contains 
multiple subtypes of inspiratory-related neurons that can be differentiated based on 
embryonic origin (Dbx1), peptide (SST) or peptide receptor (NK1, µ-opioid) expression, 
presence or absence of pacemaker properties and whether they are excitatory 
(glutamatergic) or inhibitory (GABAergic). The high sensitivity of the preBötC network to 
P2Y1 receptor excitation suggests that there may be a specific excitatory, ATP-sensitive 
population of preBötC neurons that either generates rhythm or provides drive to rhythm 
generating neurons. In contrast, if diverse excitatory and inhibitory preBotC inspiratory 
neurons are ubiquitously excited by ATP, one might predict blunted network sensitivity to 
ATP. As an initial foray into this important question, we simply asked whether all 
inspiratory modulated preBötC neurons are sensitive to P2Y1 receptor activation. As above, 
we used Ca
2+
-imaging of Fluo4-loaded rhythmic slices, identified inspiratory neurons based 
on rhythmic Ca
2+ 
oscillations in phase with XII nerve output and counted cells that did or 
did not respond to MRS 2365 with an increase in Ca
2+ 
fluorescence. In these experiments, 
MRS 2365 was bath-applied to activate as many neurons as possible and to prevent false 
negatives that can occur with local application when the drug does not diffuse from the 
pipette to the neuron in question. Neurons were only counted as weak- or nonresponders if 
there were other neurons in the same field of view that showed a strong response to MRS 
2365. When all the data were grouped, 20 neurons from 7 slices showed an average 
30.8+6.8% increase in fluorescence above baseline (data not shown). However, these 20 
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neurons could be divided into weak/non-responders and responders. Eight of the 20 
neurons responded to MRS 2365 with an average increase in fluorescence of only 
6.5+2.8%. The remaining 12 neurons were on average 7 times more sensitive, responding 
with a average 46.9+10.4% increase in fluorescence.  
To explore the signaling pathways through which ATP excites preBötC glial cells, 
glia were isolated from preBötC tissue punches and grown in culture using sorbitol in place 
of glucose as the metabolic substrate since only glia can utilize sorbitol. Cultures were 
loaded with Fluo-4-AM. Local application of ATP (10 µM, 10 s) evoked a 3.08 ± 0.2-fold 
increase in Ca
2+ 
related fluorescence (Fig. 11), which we have shown previously is 
primarily mediated by P2Y1 receptors (i.e., it is blocked by MRS 2279 but neither suramin 
nor PPADS (Huxtable et al., 2010). Images of baseline fluorescence, the peak ATP 
response in control and after bath application of the SERCA blocker, thapsigargin (50 nM, 
30 min), are shown for a group of cultured glial cells in Fig. 11A, along with the time 
course of fluorescence changes for four of these cells in Fig. 11B. Bath application of 
thapsigargin virtually blocked the ATP-evoked increase in Ca
2+ 
related fluorescence which 
rose to only 1.18 ± 0.03 of baseline (Fig. 11B, n = 53 cells, p<0.001, paired t-test).  
 
ATP-induced excitation of preBötC neurons does not involve glia-derived glutamate 
 
PreBötC astrocytes respond to hypoxia with an increase in Ca
2+
i and exocytotic 
release of ATP (Angelova, et al 2015). They also respond to ATP (Fig. 11; (Huxtable et al., 
2010), raising the possibility that during hypoxia, the autocrine/paracrine activation of 
astrocytes by ATP evokes additional gliotransmitter release that contributes to the HVR 
(Fig 1. vi). ATP and glutamate are major gliotransmitters that are released from cultured 
preBotC glia in response to hypoxia (Angelova et al., 2015) or ATP, respectively (Huxtable 
et al 2010). We asked whether activation of astrocytes by ATP can evoke the release of 
gliotransmitters that, in turn, affect the excitability of inspiratory neurons. We tested this 
indirectly by determining whether stimulation of astrocytes with exogenous ATP evokes 
glutamate-mediated excitation of inspiratory neurons. In rhythmic slices, we obtained 
whole-cell voltage clamp recordings from preBötC inspiratory neurons, identified by 
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rhythmic synaptic inputs in phase with inspiratory-related bursts in the XII nerve. We then 
applied TTX (0.5 µM) to block action potential dependent transmitter release and compared 
the neuronal response to locally applied ATP before and during application of glutamate 
receptor antagonists, CNQX (10 µM) and AP5 (100 µM)/MK-801 (100 µM) (n=8). 
CNQX/AP5 was used in 3 of 8 experiments while CNQX/MK-801 was used in the other 5. 
Data were pooled since effects of AP5 and MK801 were the same. Because locally applied 
ATP can stimulate astrocytes and neurons, we predicted that if glial-derived glutamate 
contributes to the neuronal ATP response, the ATP current would decrease in CNQX and 
AP5/MK-801. Due to the potential for time-dependent reduction in the amplitude of ATP 
currents, data obtained in the CNQX and AP5/MK-801 protocol were compared with a 
time-matched control group that received repeated ATP injections at 15 min intervals. ATP 
currents are reported as a ratio of the difference between the ATP current amplitudes 
evoked in the first and second applications divided by the first current. A value of zero 
indicates that the first and second ATP currents were the same, a negative value indicates 
the second response was smaller than the first and vice versa. Fig. 12A shows a 
representative voltage clamp recording from an inspiratory neuron and currents evoked by 
ATP in control (pre-TTX, rhythmic inspiratory synaptic currents are present), after TTX 
and again after application of CNQX and AP5. The current traces and group data both 
indicate that there is no effect of glutamate receptor antagonism on the ATP current. The 
ATP current evoked in TTX plus CNQX+AP5/MK-801 groups was 0.2 ± 8.0% smaller 
than the first. In the time-control group, ATP responses decreased 6.4 ± 4.7% between first 
and second applications. We did not examine ATP-evoked ATP release from astrocytes 
because P2 receptor antagonists would block the initial ATP response.  
 
DISCUSSION  
 
The biphasic ventilatory response of mammals to acute, moderate hypoxia 
comprises an initial, phase I increase in the first minute that is attributed to peripheral 
chemoreceptors, followed by a centrally-mediated secondary depression over several 
minutes to a new steady state phase II level. Our data complement emerging evidence of a 
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central component to the excitation where glia act as hypoxia sensors and release ATP, 
exciting the respiratory network and offsetting the secondary respiratory depression 
(Angelova et al., 2015). We advance mechanistic understanding by showing that the 
actions of ATP in the HVR are mediated in the preBötC through activation of P2Y1 
receptors that increase inspiratory frequency in vitro via thapsigargin-sensitive increases in 
[Ca
2+
]i that occur in both inspiratory neurons and astroglia.  
 
The role of glia and ATP in phase I and phase II of the hypoxic ventilatory response  
 
Evidence for gliotransmission in the intact CNS is sparse, reflecting the difficulty of 
selectively manipulating glial function. The contribution of gliotransmission to the HVR 
was first demonstrated by the reduction of the HVR in freely-moving rats following 
blockade of glial exocytosis through bilateral expression of TeLC in preBötC/VRC 
astrocytes (Angelova et al., 2015). Here, in paralyzed, mechanically ventilated rats, 
blockade of vesicular transmitter release in glia using TeLC suggests that gliotransmission 
contributes to both phases of the HVR.  
Unilateral microinjection of MRS 2279 into the preBötC, in contrast, did not affect 
the phase I increase, indicating that P2Y1 receptors in the preBötC do not contribute. Two 
protocol differences might account for this discrepancy. First, since TeLC blocks all 
vesicular release mechanisms but MRS 2279 selectively antagonizes P2Y1 receptors, the 
reduction of ventilation in phase I by TeLC may indicate a contribution of a non-P2Y1 
receptor-mediated component. Astrocytes release multiple transmitters, including glutamate 
and D-serine, that could stimulate ventilation. ATP evokes glutamate release from cultured 
preBötC glia (Huxtable et al., 2010), but stimulation of glia in rhythmic slices with ATP 
does not cause glutamatergic excitation of inspiratory neurons (Fig. 12). 
Second, the region of the brainstem affected was different between TeLC and MRS 
2279 protocols. TeLC injections were bilateral and centered in the preBötC, but expression 
extended up to >500 µm rostrally and caudally from the center of the injection site in 
preBötC. The MRS 2279 injections were unilateral and, if MRS 2279 and DLH have 
similar diffusion profiles, likely extended less than 200 µm. Given that the bulk of evidence 
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supports that the phase I response is mediated by carotid body chemoreceptors (Bureau et 
al., 1985; Fung et al., 1996; Prabhakar, 2000), the physiological significance of the TeLC-
mediated inhibition of the phase I response must be interpreted cautiously until the 
underlying mechanism is established.  
Our conclusion that gliotransmission contributes to the HVR depends on the 
selectivity of the bidirectional sGFAP-based vector system to interfere with exocytosis only 
in astrocytes. Glial specificity of this vector system (Liu et al., 2008; Gourine et al., 2010; 
Tang et al., 2014), and efficacy of TeLC in blocking exocytosis have been established 
(Angelova et al., 2015). Our analysis of transfected brain sections further suggests that 
TeLC expression is specific to astrocytes when under the control of the sGFAP promoter; 
no cells were detected that expressed eGFP and displayed NeuN immunoreactivity. 
 
ATP acts via P2Y1 receptors to increase ventilation in vivo 
 
P2 receptors comprise seven ionotropic P2X (North, 2002) and eight metabotropic 
P2Y (Abbracchio et al., 2003) subtypes. P2Y1 receptor immunolabeling is prevalent 
throughout the VLM (Fong et al., 2002) and overlaps with intense NK1 receptor 
expression, an established marker of the preBötC. Indeed, P2Y1 receptors underlie the 
excitatory actions of ATP in the preBötC in vitro (Lorier et al., 2007). Here we translate 
these in vitro findings and reveal, using unilateral injections of MRS 2279, that endogenous 
activation of preBötC P2Y1 receptors in vivo increases ventilation and attenuates the 
secondary hypoxic respiratory depression. The fact that antagonists were only applied 
unilaterally means that our measurements may underestimate the magnitude of the P2Y1 
receptor-mediated increases in ventilation during hypoxia. Whether P2Y1 receptors are the 
only P2 receptor subtype involved in the HVR is uncertain, as  a variety of P2 receptors are 
expressed in the VRC (Thomas et al., 2001; Fong et al., 2002; Gourine et al., 2003; Lorier 
et al., 2004; Lorier et al., 2007). Nonetheless, our data illustrate a significant role for 
P2Y1R in the ATP-induced increase in ventilation in the preBötC during hypoxia. 
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Adenosine inhibition of the preBötC network does not contribute to the hypoxic 
respiratory depression in adult rat   
 
Experiments were not designed to identify the mechanisms underlying the hypoxic 
respiratory depression, but our data provide some insight. First, the P2Y1 receptor-mediated 
attenuation indicates that the secondary depression is not shaped by a single inhibitory 
mechanism. Second, adenosine inhibition of the preBötC network does not contribute to the 
depression in adult rats. The enhanced hypoxic respiratory depression observed in adults 
rats expressing the ectonucleotidase TMPAP in the preBötC and VRC (Angelova et al., 
2015) is due to degradation of excitatory ATP rather than accumulation of adenosine. Also, 
hypoxia-induced adenosine release has been detected in the NTS of adult rats, but not in the 
VLM (Gourine et al., 2002). 
Developmentally, adenosine plays a more important role. An A1 receptor inhibitory 
mechanism is implicated in the secondary hypoxic depression in a host of 
premature/newborn mammals including pigs, sheep, (Moss, 2000), rats and mice (Funk et 
al., 2008; Huxtable et al., 2009; Zwicker et al., 2011). Developmental analyses are required 
in multiple species to assess whether A1 inhibitory mechanisms disappear postnatally, as 
occurs in P2-3 rats (Herlenius et al., 1997; Huxtable et al., 2009). Medullary and 
suprapontine A2a receptor-mediated excitation of GABAergic inhibitory neurons may also 
contribute to the depression in piglets and fetal sheep (Koos & Maeda, 2001; Koos et al., 
2001; Wilson et al., 2004). 
 
Signaling pathways of the P2Y1 receptor-mediated excitation; neurons versus glia 
 
The only identified source of extracellular ATP during hypoxia is from astrocytes 
(Angelova et al., 2015). Thus, our working hypothesis is that, during hypoxia, astrocyte-
derived ATP increases inspiratory frequency primarily through excitation of preBötC 
inspiratory neurons but also through autocrine/paracrine excitation of astrocytes causing 
further gliotransmitter release (Fig. 1 iii, vi). Consistent with this hypothesis, both preBötC 
inspiratory neurons (in slices, Fig. 10) and preBötC glia (in slices and culture (Fig. 11) 
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(Huxtable et al., 2010)) respond to ATP via a P2Y1 receptor signaling pathway that 
involves a thapsigargin-sensitive increase in [Ca
2+
]i and a neuronal inward current (Lorier et 
al., 2008). The ion channels underlying this inward current have yet to be identified, though 
candidates have been proposed (Rajani et al., 2015). 
ATP-induced excitation of neurons is clearly involved in preBötC excitation. 
However, a role for autocrine/paracrine excitation of astrocytes by ATP remains to be 
established. Autocrine/paracrine excitation was first implicated with the observations that 
glial toxins attenuate the frequency increase evoked by ATP in the preBötC in vitro and 
that cultured preBötC astrocytes release glutamate in response to ATP (Huxtable et al., 
2010). In contrast, imaging of cultured brainstem astrocytes suggests that ATP does not 
signal via paracrine/autocrine mechanisms; low pH and hypoxia-evoked fusion of putative 
ATP-containing vesicles was unaffected by ATP degrading enzymes or P2Y1 receptor 
antagonists (Kasymov et al., 2013; Angelova et al., 2015). The sparse nature of these 
astrocyte cultures could have compromised detection of autocrine/paracrine signaling. 
However, our whole-cell data showing that ATP does not evoke glutamatergic excitation of 
inspiratory neurons suggest that preBötC astrocytes in situ do not respond to ATP by 
releasing a transmitter, and that autocrine/paracrine ATP signaling may not contribute to 
the HVR. 
 
[Ca
2+
]i increases contribute to P2Y1 receptor-mediated inspiratory frequency increase 
 
Analysis of recombinant receptors suggests that P2Y1 receptors predominantly 
signal through the Gαq/11 pathway, which involves activation of PLC, release of Ca
2+
 from 
intracellular stores, and DAG-mediated activation of protein kinase C (Simon et al., 1995; 
von Kugelgen & Wetter, 2000; Sak & Illes, 2005). Here we show that an increase in [Ca
2+
]i 
contributes to the P2Y1-mediated frequency increase in vitro, which implicates a [Ca
2+
]-
dependent, second messenger pathway that is dependent on [Ca
2+
]i. The ATP/MRS 2365-
mediated frequency increase, however, was not completely blocked by EGTA-AM or 
thapsigargin (Fig. 9). Thus, either the block of [Ca
2+
]i changes was incomplete or Ca
2+
-
insensitive pathways may contribute. P2Y1 receptors can also signal through Gαi and alter 
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ion channel activity through the membrane-delimited βγ subunit without changing [Ca2+]i 
(Brown et al., 2000; Filippov et al., 2000; Aoki et al., 2004). To fully elucidate these 
mechanisms, a deeper exploration of signalling pathways and downstream candidate ion 
channels underlying the P2Y1-evoked excitation of the preBötC is required (Rajani et al., 
2015). 
 
Significance 
 
Understanding the multitude of factors that determine the dynamics of the HVR is key in 
the development of strategies to counteract the hypoxia-induced depression of breathing. 
We have identified an endogenous P2Y1 receptor mechanism that attenuates this depression 
in adults and is active in embryonic stages through to adulthood in mammals. Degradation 
of ATP in the preBötC will contribute to the depression by removing excitatory actions of 
ATP, but also by producing adenosine, which is inhibitory in the perinatal period and 
variably into adulthood. Strategies to minimize the hypoxic depression of ventilation 
should aim to enhance P2Y1 receptor-mediated signaling, inhibit ATP degradation and 
enhance removal of adenosine from the extracellular space. 
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FIGURE CAPTIONS  
 
Figure 1: Purinergic modulation of respiratory rhythm: a working hypothesis. 
At the synapse of two preBötC inspiratory neurons, volleys of action potentials during 
inspiration in the presynaptic neuron evoke glutamate release, exciting postsynaptic 
neurons via ionotropic (GluR) and metabotropic (mGluR) receptors on preBötC inspiratory 
neurons. During hypoxia, astrocytes sense changes in O2, causing increases in intracellular 
calcium (i), resulting in the exocytotic release of gliotransmitters, including ATP (ii). ATP 
acts via P2Y1 receptors located on preBötC neurons (iii), causing a release of Ca
2+
 from 
intracellular stores mediated by DAG/IP3 (iv), and the modulation of downstream ion 
channels, [Ca
2+
]i, or the activation of protein kinase C (PKC) (v). Autocrine/paracrine of 
astrocytes by ATP may also contribute (vi). !
 
Figure 2: Expression of tetanus toxin light chain (TeLC) protein in medullary 
astrocytes attenuates the hypoxic ventilatory response. 
A) Representative recordings obtained in naïve control and TeLC-expressing animals 
! $+!
showing changes in integrated phrenic nerve activity (∫PN), instantaneous frequency (inst. 
freq., breaths per min, BPM) and blood pressure during 5.5 min of exposure to 10% O2. B) 
Time courses of relative frequency, integrated phrenic nerve amplitude (∫PNA) and 
ventilatory output (frequency × ∫PNA) calculated for the three groups: naïve controls 
(n=10), viral controls (n=6) expressing eGFP in astroglia, and rats expressing eGFP and 
TeLC in astroglia (n=6). Phases I and II of the HVR are shaded in grey. C) Comparisons of 
phase I and II parameters across the three groups reveals a significant decrease in 
ventilatory output of TeLC expressing rats during both phases I and II (p<0.5, One-way 
ANOVA, Tukey post-hoc test). 
 
Figure 3: Viral expression was centered at the level of the preBötC and limited to 
astrocytes. A) Schematic showing relative location of peak viral expression with respect to 
the preBötC in adult rats targeted with AVV-sGFAP-eGFP-TeLC. Inferior olive dorsal 
(IOD), inferior olive medial (IOM), inferior olive principal (IOP), 4
th
 ventricle (IV), 
nucleus ambiguus (NA), pyramidal tract (PY), rostral ventrolateral medulla (RVL), spinal 
trigeminal tract (Sp5), spinal trigeminal interpolar (Sp5I), solitary tract (Sol). Viral 
expression was centered in the preBötC and dropped off substantially 500 µM rostral and 
caudal to the injection site that was centered in the preBötC. B) The region expressing 
TeLC-eGFP adenovirus is centered in the region containing a high density of NK1 receptor 
expressing neurons, are present in. C) Double-labeling of cells with the neuronal marker 
NeuN and the glial specific AAV, detected via eGFP, was not detected. Ten NeuN labeled 
cells are circled to facilitate comparison between images). 
!
Figure 4: Functional identification of preBötC via microinjections of DLH. Unilateral 
injection of DLH (10 mM) into the VLM of urethane-anesthetized, paralyzed adult rats 
while measuring instantaneous respiratory frequency (inst. freq.) from phrenic nerve 
activity (∫PN). A) Unilateral injection of DLH into the preBötC produces a robust increase 
in respiratory frequency. B) Injection of DLH 200 µm rostral to the preBötC (presumably 
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in the BötC) reduced inspiratory frequency. C) DLH injection 300 µm caudal to the 
preBötC had minimal effect on inspiratory rhythm. 
Figure 5: Activation of P2Y1 receptors in the preBötC of adult rat in vivo with MRS 
2365 (1 mM) evokes an increase in respiratory frequency and a decrease in tidal 
volume (VT) A) Airflow and diaphragm (DIA) EMG recordings show the response of an 
adult anesthetized vagotomized rat to unilateral injection of MRS 2365 (1mM, 200nl) into 
the preBötC. B) Time course of instantaneous frequency (inst. freq.), VT, and minute 
ventilation (V̇E) responses evoked by a single injection of MRS 2365.  C) Group data (n=8) 
illustrating the change in frequency, VT and V̇E relative to control (* indicates significant 
different from predrug control values , p< 0.05, paired t- test). D) Schematic showing 8 
injection sites. Inferior olive dorsal (IOD), inferior olive medial (IOM), inferior olive 
principal (IOP), 4
th
 ventricle (IV), nucleus ambiguous (NA), pyramidal tract (PY), rostral 
ventrolateral medulla (RVL), spinal trigeminal tract (Sp5), spinal trigeminal interpolar 
(Sp5I), solitary tract (Sol). 
Figure 6: Adenosine (500 µM) microinjected into the preBötC of adult rat in vivo has 
no effect on respiratory frequency or tidal volume (VT). A) Airflow, diaphragm (DIA) 
and genioglossus (GG) EMG recordings show the response of an adult anesthetized 
vagotomized rat to unilateral injection of adenosine into the preBötC. B) Airflow, 
diaphragm (DIA) and genioglossus (GG) EMG recordings show the response of an adult 
anesthetized vagotomized rat to injection of DLH (1 mM) into the preBötC. C) Group data 
illustrating the change in frequency and VT relative to control (n=8) (* indicates significant 
difference from predrug controls values, (paired t-test P< 0.05). D) Schematic showing 8 
injection sites in relation to inferior olive dorsal (IOD), inferior olive medial (IOM), 
inferior olive principal (IOP), 4
th
 ventricle (IV), nucleus ambiguus (NA), pyramidal tract 
(PY), rostral ventrolateral medulla (RVL), spinal trigeminal tract (Sp5), spinal trigeminal 
interpolar (Sp5I), solitary tract (Sol). E) Tissue section showing injection site marked with 
fluorescent microspheres (yellow). PreBötC neurons (NK1
+
) are present in the region of the 
injection site. 
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Figure 7: Unilateral inhibition of P2Y1 receptors in the preBötC of adult paralyzed 
rats in vivo with MRS 2279 increases the secondary hypoxic respiratory depression. 
A) Representative traces showing changes in integrated phrenic nerve activity (∫PN) and 
instantaneous frequency (inst. freq. BPM) evoked by exposure to 5 min of 10% O2 
following injection of vehicle (HEPES) or MRS 2279 into the preBötC. B) (Left) Time 
courses of relative frequency, integrated phrenic nerve amplitude (∫PNA) and ventilatory 
output (frequency × ∫PNA) calculated before and after injection of MRS 2279 (n=6). 
Phases I and II of the HVR are shaded in grey. (Right) Comparisons of phase I and II 
parameters between vehicle and MRS 2279 responses (* indicates significant difference 
between control (HEPES) and MRS 2279 trials p <0.5, paired t-test). C) Schematic 
showing 6 injection sites. Inferior olive dorsal (IOD), inferior olive medial (IOM), inferior 
olive principal (IOP), 4
th
 ventricle (IV), nucleus ambiguus (NA), pyramidal tract (PY), 
rostral ventrolateral medulla (RVL), spinal trigeminal tract (Sp5), spinal trigeminal 
interpolar (Sp5I), solitary tract (Sol).  
Figure 8:  The hypoxic ventilatory response does not change with repeated exposure; 
time-matched controls. A) Representative traces from the same animal showing changes 
in integrated phrenic nerve activity (∫PN) and instantaneous frequency (inst. freq., BPM) 
during two consecutive hypoxic exposures (1 hour apart) following stereotaxic injection of 
vehicle (HEPES) into the preBötC. B) (Left) Time courses of relative frequency, integrated 
phrenic nerve amplitude (∫PNA) and ventilatory output (frequency × ∫PNA) calculated 
before and after injection of MRS 2279 (n=6). Phases I and II of the HVR are shaded in 
grey. (Right) The phase I and II components of the HVR were similar during consecutive 
exposure to hypoxia under control conditions (i.e., after HEPES injection)(p>0.5, paired t-
test). 
Figure 9: Increases in [Ca
2+
]i contribute to the P2Y1 receptor mediated frequency 
increase in vitro. A) Representative traces of integrated hypoglossal nerve output (∫XII) 
evoked in response to P2Y1 agonist MRS 2365 (10s, 100 µM) before and after the local 
application of the cell permeable calcium chelator EGTA-AM (1 mM) to the preBötC. B) 
Box plot summarizing group data (n = 6, p = 0.0047, paired t-test). C) Representative traces 
! $#!
∫XII nerve output evoked in response to MRS 2365 (10s, 100 µM) in control and after local 
application of thapsigargin (30 min, 200 µM). D) Box plot summarizing group data (n= 6 , 
p=0.007, paired t-test). Time matched control experiments showed no significant effect on 
the MRS 2365 response of locally applying vehicle (0.2% DMSO) into the preBötC for 30 
minutes of (n=5, p>0.05, paired t-test).!!
Figure 10: Activation of P2Y1 receptors on preBötC inspiratory neurons in vitro 
evokes a thapsigargin-sensitive, increase in [Ca
2+
]i. A) Multiphoton images of baseline 
Fluo-4
 
fluorescence indicating [Ca
2+
]i in 5 inspiratory neurons at a single optical plain (top), 
inspiratory-related oscillations in [Ca
2+
]i and the peak [Ca
2+
]i increase evoked in response 
to locally applied MRS 2365 (100 µM, 10 s) (bottom) B) [Ca2+]i increases in the neurons of 
(A) are synchronous with ∫XII and their responses to locally applied MRS 2365 (100 µM, 
10 s). C) Group data showing an approximate 50% increase in peak Fluo-4 fluorescence in 
response to local application of MRS 2365 (100 µM, 10 s) over inspiratory preBötC 
neurons (n=18, 5 slices, p <0.0001, paired t-test); A.U., arbitrary units. D) Multiphoton 
images of Fluo-4  Ca
2+
 fluorescence in 2 inspiratory neurons at a single optical plain at 
baseline (top), at the peak of two control MRS 2365-evoked (10 µM, 1 min, bath 
application) Ca
2+ 
fourescence responses  (top middle, bottom middle), seperated by 30 
minute intervals. The bottom image shows the response evoked by MRS 2365 after bath 
application of thapsigargin (100 µM, 30 min). E) Traces of Fluo-4 Ca2+ flourescent 
responses evoked by MRS2365 in the same neurons shown in (D). F) Group data 
comparing the decrease in peak MRS 2365 evoked Fluo-4  Ca
2+
 response that occurred 
between control response 1 and 2 with the decrease in the MRS 2365 evoked Ca
2+
 response 
that occurred between the second control MRS 2365 response and the MRS 2365 response 
in thapsigargin/CPA (n=12, p<0.0001, paired t-test). 
 
Figure 11: Responses of cultured preBötC glia to ATP are sensitive to depletion of 
intracellular calcium stores. A) Images showing a phase contrast image of cultured glia 
(far left panel), and fluo-4 Ca
2+ 
fourescence under baseline conditions (middle-left panel), 
during local application of ATP (100 µM, 10 s,) (middle-right panel), and during local 
! $$!
application of ATP after pre-application of SERCA inhibitor thapsigargin (50 nm, 30 min) 
(far right panel). B) Time course of ATP-evoked fluorescence changes measured from 4 
ROIs (numbered in A) in control (left), and after thapsigargin application (middle). Group 
data (n=54) showing relative changes in fluorescence (Fpeak/Fbaseline) in response to ATP and 
to ATP in the presence of thapsigargin (right) reveal that thapsigargin significantly reduced 
the ATP-evoked increase in Ca
2+
 fluorescence (n=53, p<0.001, paired t-test).  
 
Figure 12: Effect of CNQX and AP5/MK-801 on ATP currents evoked in preBötC 
inspiratory neurons in TTX.  
A) Representative traces showing an ATP current evoked in an inspiratory preBotC neuron 
in a rhythmic slice (note inspiratory synaptic currents pre-TTX), after TTX and again in 
TTX after bath application of CNQX (10 µM) and AP5 (100 µM). B) Group data 
comparing the relative reduction in the ATP current that occurs with consecutive 
applications in a time matched-control group (n=6) with reduction that was produced by 
CNQX+AP5/MK-801 group (n=8). CNQX and AP5/MK-801 did not affect the amplitude 
of ATP-induced inward currents (p>0.05, unpaired t-test). 
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